1. Home
  2. MRVI vs NUS Comparison

MRVI vs NUS Comparison

Compare MRVI & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.41

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Logo Nu Skin Enterprises Inc.

NUS

Nu Skin Enterprises Inc.

HOLD

Current Price

$7.65

Market Cap

343.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRVI
NUS
Founded
2014
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Pharmaceuticals
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
472.8M
343.1M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
MRVI
NUS
Price
$3.41
$7.65
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$4.13
N/A
AVG Volume (30 Days)
1.9M
392.0K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
3.08%
EPS Growth
14.29
207.80
EPS
N/A
3.18
Revenue
$185,743,000.00
$3,176,718,000.00
Revenue This Year
$12.44
N/A
Revenue Next Year
$7.90
$7.14
P/E Ratio
N/A
$2.45
Revenue Growth
N/A
48.98
52 Week Low
$1.70
$5.32
52 Week High
$4.11
$14.62

Technical Indicators

Market Signals
Indicator
MRVI
NUS
Relative Strength Index (RSI) 60.33 51.05
Support Level $3.25 $7.03
Resistance Level $3.99 $10.90
Average True Range (ATR) 0.17 0.22
MACD 0.07 0.11
Stochastic Oscillator 81.08 71.86

Price Performance

Historical Comparison
MRVI
NUS

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

Share on Social Networks: